Vivos Therapeutics (VVOS) Q4 2023 Earnings

28MarConfirmed
Q1 2023
Q2 2023
Q3 2023
Q4 2023
-3.05
-2.07
-1.08
-0.1

Details

Expected EPS
-1.9
Actual EPS
-3.05
Surprise EPS
-1.15
Surprise Percent
+60.53%

Description

Vivos Therapeutics (VVOS) has reported earnings of -3.05 per share for Q4 2023.

0 Comments

Share your thoughts